Kayser, Sabine, and Richard F. Schlenk. 2020. “All Patients With AML and FLT3-ITD Should Be Transplanted in First Remission. Also in the Era of Tyrosine Kinase Inhibitors? - the PRO”. Haematologica, September. Pavia, Italy. https://doi.org/10.3324/haematol.2025.288785.